CD163 and lobular neoplasia: Previous studies reported elevated urinary sCD163 (u-sCD163) levels in patients with active lupus nephritis (LN) and antibody-associated glomerulonephritis (ANCA-GN), suggesting that u-sCD163 is a potential biomarker of kidney inflammation in LN and ANCA-GN (12–14).